(OPTX) Syntec Optics Holdings - Ratings and Ratios
Polymer Optics, Optical Assemblies, Electro-Optics, Molded Optics, Thin Films
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 124% |
| Value at Risk 5%th | 172% |
| Relative Tail Risk | -15.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.06 |
| Alpha | 57.23 |
| CAGR/Max DD | -0.30 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.589 |
| Beta | 1.723 |
| Beta Downside | 1.751 |
| Drawdowns 3y | |
|---|---|
| Max DD | 92.96% |
| Mean DD | 58.57% |
| Median DD | 77.37% |
Description: OPTX Syntec Optics Holdings January 08, 2026
Syntec Optics Holdings, Inc. (NASDAQ: OPTX) designs, manufactures, and assembles integrated optics and photonics components for defense, medical, and consumer markets, offering polymer-based optics, molded polymer and glass components, opto-mechanical parts, nano-machining, thin-film coatings, and related design and assembly services. The firm was founded in 1981 and operates from Rochester, New York, classifying under the Electronic Components sub-industry in the U.S. market.
Key quantitative signals (as of the most recent FY 2024 filing) include a revenue run-rate of roughly $45 million, a gross margin hovering near 38 % and R&D intensity around 12 % of sales-both in line with peers in the high-precision photonics niche. The sector is being propelled by two macro drivers: sustained U.S. defense budget growth (the DoD’s FY 2025 budget projects a 4 % increase in optics-related procurement) and the expanding demand for minimally invasive medical imaging, which the global photonics market is expected to grow at a CAGR of ~9 % through 2030.
For a deeper, data-driven dive into OPTX’s valuation metrics and comparable peers, you may find ValueRay’s analytics platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-2.37m TTM) > 0 and > 6% of Revenue (6% = 1.68m TTM) |
| FCFTA -0.07 (>2.0%) and ΔFCFTA -12.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.27% (prev 12.80%; Δ -3.53pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.04 (>3.0%) and CFO -1.03m > Net Income -2.37m (YES >=105%, WARN >=100%) |
| Net Debt (10.8m) to EBITDA (412.5k) ratio: 26.16 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (36.9m) change vs 12m ago 15.44% (target <= -2.0% for YES) |
| Gross Margin 19.84% (prev 26.90%; Δ -7.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 106.3% (prev 104.1%; Δ 2.13pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -3.15 (EBITDA TTM 412.5k / Interest Expense TTM 747.6k) >= 6 (WARN >= 3) |
Altman Z'' 1.56
| (A) 0.11 = (Total Current Assets 14.6m - Total Current Liabilities 12.0m) / Total Assets 24.6m |
| (B) 0.29 = Retained Earnings (Balance) 7.20m / Total Assets 24.6m |
| (C) -0.09 = EBIT TTM -2.36m / Avg Total Assets 26.4m |
| (D) 0.49 = Book Value of Equity 7.21m / Total Liabilities 14.8m |
| Total Rating: 1.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 28.85
| 1. Piotroski 2.50pt |
| 2. FCF Yield -2.98% |
| 3. FCF Margin -6.05% |
| 4. Debt/Equity 1.16 |
| 5. Debt/Ebitda 26.16 |
| 6. ROIC - WACC (= -19.10)% |
| 7. RoE -20.64% |
| 8. Rev. Trend 16.69% |
| 9. EPS Trend -10.09% |
What is the price of OPTX shares?
Over the past week, the price has changed by -17.93%, over one month by +165.73%, over three months by +36.20% and over the past year by +113.48%.
Is OPTX a buy, sell or hold?
What are the forecasts/targets for the OPTX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 3.5 | -9.2% |
OPTX Fundamental Data Overview January 15, 2026
P/B = 16.7106
Revenue TTM = 28.1m USD
EBIT TTM = -2.36m USD
EBITDA TTM = 412.5k USD
Long Term Debt = 1.29m USD (from longTermDebt, last quarter)
Short Term Debt = 8.57m USD (from shortTermDebt, last quarter)
Debt = 11.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.8m USD (from netDebt column, last quarter)
Enterprise Value = 56.9m USD (46.2m + Debt 11.4m - CCE 577.9k)
Interest Coverage Ratio = -3.15 (Ebit TTM -2.36m / Interest Expense TTM 747.6k)
EV/FCF = -33.52x (Enterprise Value 56.9m / FCF TTM -1.70m)
FCF Yield = -2.98% (FCF TTM -1.70m / Enterprise Value 56.9m)
FCF Margin = -6.05% (FCF TTM -1.70m / Revenue TTM 28.1m)
Net Margin = -8.44% (Net Income TTM -2.37m / Revenue TTM 28.1m)
Gross Margin = 19.84% ((Revenue TTM 28.1m - Cost of Revenue TTM 22.5m) / Revenue TTM)
Gross Margin QoQ = 12.29% (prev 23.31%)
Tobins Q-Ratio = 2.32 (Enterprise Value 56.9m / Total Assets 24.6m)
Interest Expense / Debt = 1.89% (Interest Expense 214.4k / Debt 11.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.86m (EBIT -2.36m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.22 (Total Current Assets 14.6m / Total Current Liabilities 12.0m)
Debt / Equity = 1.16 (Debt 11.4m / totalStockholderEquity, last quarter 9.81m)
Debt / EBITDA = 26.16 (Net Debt 10.8m / EBITDA 412.5k)
Debt / FCF = -6.35 (negative FCF - burning cash) (Net Debt 10.8m / FCF TTM -1.70m)
Total Stockholder Equity = 11.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.97% (Net Income -2.37m / Total Assets 24.6m)
RoE = -20.64% (Net Income TTM -2.37m / Total Stockholder Equity 11.5m)
RoCE = -18.46% (EBIT -2.36m / Capital Employed (Equity 11.5m + L.T.Debt 1.29m))
RoIC = -8.97% (negative operating profit) (NOPAT -1.86m / Invested Capital 20.8m)
WACC = 10.13% (E(46.2m)/V(57.5m) * Re(12.26%) + D(11.4m)/V(57.5m) * Rd(1.89%) * (1-Tc(0.21)))
Discount Rate = 12.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 7.44%
Fair Price DCF = unknown (Cash Flow -1.70m)
EPS Correlation: -10.09 | EPS CAGR: 0.0% | SUE: -0.47 | # QB: 0
Revenue Correlation: 16.69 | Revenue CAGR: 0.01% | SUE: N/A | # QB: 0
Additional Sources for OPTX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle